Review



u 937 cell lines  (DSMZ)


Bioz Verified Symbol DSMZ is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    DSMZ u 937 cell lines
    U 937 Cell Lines, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 363 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/U-937/pm42929838-44-2-14
    Average 96 stars, based on 363 article reviews
    u 937 cell lines - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    other:


    Article Title: KRT15 identified by scRNA-Seq and machine learning as stemness regulator and prognostic biomarker in ESCC
    Article Snippet: Human: KYSE180 cells , DSMZ , ACC-379.

    Article Title: Inducing ferroptosis to impede metastasis by inhibiting the calcium channel TRPC6
    Article Snippet: CAL-51 , Leibniz Institute DSMZ, Germany , ACC-302.


    Article Title: Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignancies
    Article Snippet: Pierce High pH Reversed-Phase Peptide Fractionation Kit , Thermo Scientific , 84868.

    Article Title: KRT15 identified by scRNA-Seq and machine learning as stemness regulator and prognostic biomarker in ESCC
    Article Snippet: Human: KYSE150 cells , DSMZ , ACC-375.


    Viability Assay:

    Article Title: Solid forms comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same
    Article Snippet: .. Cell Proliferation and Viability Assay Using SU-DHL-4 Cell Line: The following exemplary assay uses a DLBCL cell line, for example, the SU-DHL-4 cell line (Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH [DSMZ]: catalogue number ACC-495) at 120 hours post-treatment. ..



    Similar Products

    96
    DSMZ u 937 cell lines
    U 937 Cell Lines, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/U-937/pm42929838-44-2-14
    Average 96 stars, based on 1 article reviews
    u 937 cell lines - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    DSMZ jurl mk1
    Jurl Mk1, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/JURL-MK1/pm42929838-44-0-14
    Average 94 stars, based on 1 article reviews
    jurl mk1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    DSMZ human t cell leukemia cells
    Human T Cell Leukemia Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/JURKAT/pm42921456-91-16-22
    Average 97 stars, based on 1 article reviews
    human t cell leukemia cells - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    DSMZ human burkitt lymphoma cells
    Human Burkitt Lymphoma Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/DG-75/pm42921456-91-0-7
    Average 94 stars, based on 1 article reviews
    human burkitt lymphoma cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    DSMZ nalm6 cells
    ( A ) Overview of cytosolic formaldehyde (FA) catabolism. ( B ) Heatmap depicting Log10 of the 50% FA inhibitory concentration (IC 50 ) in the presence or absence of l -buthionine-sulfoximine (BSO) at concentrations of 25 μM (H2170 cells), 50 μM <t>(Jurkat,</t> <t>Nalm6,</t> K562, and LUDLU-1 cells) or 100 μM (HCT116, H1299, A549, and T98G cells). ( C ) Representative FA viability curves normalized (norm.) to 0 μM FA for H1299 and A549 cells [mean ± SEM, n = 5 (H1299), n = 6 (A549), and two-way ANOVA (Tukey test between untreated (UT) and 100 μM BSO); for H1299: ** P = 0.0016, **** P < 0.0001, and ** P = 0.0023]. ( D ) Glutathione (GSH) levels upon 24-hour exposure to BSO [same concentrations as (B)] (mean ± SEM, n represented as dots, t test comparison between UT and BSO; * P = 0.0142, ** P = 0.0073, **** P < 0.0001). ( E ) Colony survival assay (CSA) in HCT116, H1299, and A549 in the presence of FA and/or 3.12 μM BSO for H1299 cells and 6.25 μM BSO for both HCT116 and A549 cells [mean ± SEM, n represented as dots, one-way ANOVA (Tukey test); for HCT116: **** P < 0.0001; for H1299: * P = 0.0106 and ** P = 0.0033]. ( F ) Left: GSH quantification in A549 cells expressing a nontargeting-control sgRNA (sgNTC) or sgRNAs against GSS (sg GSS ). Right: Viability in response to FA [mean ± SEM, n = 3]. ( G ) Immunoblots in A549 cells carrying an empty vector (pEV) or a vector coding for wild-type KEAP1 (p KEAP1 ). ( H ) Viability curves for A549/pEV or A549/pKEAP1 cells exposed to different concentrations of FA in the presence of 100 μM BSO [mean ± SEM, n = 3 and two-way ANOVA (Tukey test between UT and 100 μM BSO); **** P < 0.0001]. ( I ) DNA-protein cross-link (DPC) accumulation in A549/pEV and A549/pKEAP1 cells exposed to 100 μM BSO for 48 hours and to the indicated concentrations of FA for 4 hours (mean ± SEM, n = 3, one-way ANOVA in each cell line corrected by Tukey test) . Created in BioRender. https://BioRender.com/tsuwhsf .
    Nalm6 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/NALM-6/pmc13693651-162-0-8
    Average 97 stars, based on 1 article reviews
    nalm6 cells - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    lp 1  (DSMZ)
    95
    DSMZ lp 1
    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, <t>LP‐1,</t> and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.
    Lp 1, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/LP-1/pmc13685402-37-6-10
    Average 95 stars, based on 1 article reviews
    lp 1 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    DSMZ kelly human neuroblastoma cells
    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, <t>LP‐1,</t> and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.
    Kelly Human Neuroblastoma Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/KELLY/pmc13686354-46-0-6
    Average 95 stars, based on 1 article reviews
    kelly human neuroblastoma cells - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    DSMZ resazurin solution
    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, <t>LP‐1,</t> and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.
    Resazurin Solution, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/ML-1/pm42907509-450-49-61
    Average 95 stars, based on 1 article reviews
    resazurin solution - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    jeko 1  (DSMZ)
    95
    DSMZ jeko 1
    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, LP‐1, and <t>JeKo‐1</t> cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.
    Jeko 1, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/JEKO-1/pmc13685402-37-12-16
    Average 95 stars, based on 1 article reviews
    jeko 1 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    ku1919  (DSMZ)
    94
    DSMZ ku1919
    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, LP‐1, and <t>JeKo‐1</t> cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.
    Ku1919, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/acc/KU-19-19/pm42907504-1221-25-26
    Average 94 stars, based on 1 article reviews
    ku1919 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Overview of cytosolic formaldehyde (FA) catabolism. ( B ) Heatmap depicting Log10 of the 50% FA inhibitory concentration (IC 50 ) in the presence or absence of l -buthionine-sulfoximine (BSO) at concentrations of 25 μM (H2170 cells), 50 μM (Jurkat, Nalm6, K562, and LUDLU-1 cells) or 100 μM (HCT116, H1299, A549, and T98G cells). ( C ) Representative FA viability curves normalized (norm.) to 0 μM FA for H1299 and A549 cells [mean ± SEM, n = 5 (H1299), n = 6 (A549), and two-way ANOVA (Tukey test between untreated (UT) and 100 μM BSO); for H1299: ** P = 0.0016, **** P < 0.0001, and ** P = 0.0023]. ( D ) Glutathione (GSH) levels upon 24-hour exposure to BSO [same concentrations as (B)] (mean ± SEM, n represented as dots, t test comparison between UT and BSO; * P = 0.0142, ** P = 0.0073, **** P < 0.0001). ( E ) Colony survival assay (CSA) in HCT116, H1299, and A549 in the presence of FA and/or 3.12 μM BSO for H1299 cells and 6.25 μM BSO for both HCT116 and A549 cells [mean ± SEM, n represented as dots, one-way ANOVA (Tukey test); for HCT116: **** P < 0.0001; for H1299: * P = 0.0106 and ** P = 0.0033]. ( F ) Left: GSH quantification in A549 cells expressing a nontargeting-control sgRNA (sgNTC) or sgRNAs against GSS (sg GSS ). Right: Viability in response to FA [mean ± SEM, n = 3]. ( G ) Immunoblots in A549 cells carrying an empty vector (pEV) or a vector coding for wild-type KEAP1 (p KEAP1 ). ( H ) Viability curves for A549/pEV or A549/pKEAP1 cells exposed to different concentrations of FA in the presence of 100 μM BSO [mean ± SEM, n = 3 and two-way ANOVA (Tukey test between UT and 100 μM BSO); **** P < 0.0001]. ( I ) DNA-protein cross-link (DPC) accumulation in A549/pEV and A549/pKEAP1 cells exposed to 100 μM BSO for 48 hours and to the indicated concentrations of FA for 4 hours (mean ± SEM, n = 3, one-way ANOVA in each cell line corrected by Tukey test) . Created in BioRender. https://BioRender.com/tsuwhsf .

    Journal: Science Advances

    Article Title: NRF2 coordinates cystine import and glutathione use to sustain ferroptosis resistance and formaldehyde tolerance in cancer

    doi: 10.1126/sciadv.aea1431

    Figure Lengend Snippet: ( A ) Overview of cytosolic formaldehyde (FA) catabolism. ( B ) Heatmap depicting Log10 of the 50% FA inhibitory concentration (IC 50 ) in the presence or absence of l -buthionine-sulfoximine (BSO) at concentrations of 25 μM (H2170 cells), 50 μM (Jurkat, Nalm6, K562, and LUDLU-1 cells) or 100 μM (HCT116, H1299, A549, and T98G cells). ( C ) Representative FA viability curves normalized (norm.) to 0 μM FA for H1299 and A549 cells [mean ± SEM, n = 5 (H1299), n = 6 (A549), and two-way ANOVA (Tukey test between untreated (UT) and 100 μM BSO); for H1299: ** P = 0.0016, **** P < 0.0001, and ** P = 0.0023]. ( D ) Glutathione (GSH) levels upon 24-hour exposure to BSO [same concentrations as (B)] (mean ± SEM, n represented as dots, t test comparison between UT and BSO; * P = 0.0142, ** P = 0.0073, **** P < 0.0001). ( E ) Colony survival assay (CSA) in HCT116, H1299, and A549 in the presence of FA and/or 3.12 μM BSO for H1299 cells and 6.25 μM BSO for both HCT116 and A549 cells [mean ± SEM, n represented as dots, one-way ANOVA (Tukey test); for HCT116: **** P < 0.0001; for H1299: * P = 0.0106 and ** P = 0.0033]. ( F ) Left: GSH quantification in A549 cells expressing a nontargeting-control sgRNA (sgNTC) or sgRNAs against GSS (sg GSS ). Right: Viability in response to FA [mean ± SEM, n = 3]. ( G ) Immunoblots in A549 cells carrying an empty vector (pEV) or a vector coding for wild-type KEAP1 (p KEAP1 ). ( H ) Viability curves for A549/pEV or A549/pKEAP1 cells exposed to different concentrations of FA in the presence of 100 μM BSO [mean ± SEM, n = 3 and two-way ANOVA (Tukey test between UT and 100 μM BSO); **** P < 0.0001]. ( I ) DNA-protein cross-link (DPC) accumulation in A549/pEV and A549/pKEAP1 cells exposed to 100 μM BSO for 48 hours and to the indicated concentrations of FA for 4 hours (mean ± SEM, n = 3, one-way ANOVA in each cell line corrected by Tukey test) . Created in BioRender. https://BioRender.com/tsuwhsf .

    Article Snippet: Nalm6 cells and Jurkat cells were obtained from DSMZ, while K562 were sourced from ATCC.

    Techniques: Concentration Assay, Comparison, Clonogenic Cell Survival Assay, Expressing, Control, Western Blot, Plasmid Preparation

    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, LP‐1, and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.

    Journal: Molecular Oncology

    Article Title: A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

    doi: 10.1002/1878-0261.70328

    Figure Lengend Snippet: Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, LP‐1, and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.

    Article Snippet: RPMI‐8226 cells (RRID:CVCL_0014; obtained from ATCC), LP‐1 (RRID:CVCL_0012; obtained from DSMZ) and JeKo‐1 (RRID:CVCL_1865; obtained from DSMZ) were cultured in IMDM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin at 37 °C and 5% CO 2 .

    Techniques: Knock-Out, Competitive Binding Assay

    Inhibiting eIF5A hypusination and unfolded protein response (UPR) activity. (A) Western blot of eIF5A hypusination in RPMI‐8226 and LP‐1 cells treated with GC7 (6 μ m ), N = 3, one representative experiment is shown. (B) Quantification of A. Data are presented as mean ± SEM. (C) Expression of key UPR proteins upon in RPMI‐8226 and LP‐1 cells treated with GC7 (6 μ m ), N = 2, one representative experiment is shown. (D) Viability of RPMI‐8226 cells treated with TG (6 n m ), GC7 (6 μ m ), and qVD (5 μ m ) for 24 h. Data are presented as mean ± SEM, N = 3. (E) Viability of LP‐1 cells treated with TG (6 n m ), GC7 (6 μ m ), and qVD (5 μ m ) for 48 h. Data are presented as mean ± SEM, N = 3. (F) Western blot of eIF5A hypusination in RPMI8226 mock cells after TG treatment (24 h, 6 n m ), N = 4, one representative experiment is shown. Data are presented as mean ± SEM. (G) Western blot of eIF5A hypusination in RPMI8226 cells treated with BO (24 h, 20 n m ), N = 3, one representative experiment is shown. Data are presented as mean ± SEM. (H) Western blot of eIF5A hypusination in LP‐1 mock cells after TG treatment (24 h, 12 n m ), N = 4, one representative experiment is shown. Data are presented as mean ± SEM. P ‐values were calculated using student's t ‐tests, * P < 0.05, ** P < 0.01. TG, thapsigargin.

    Journal: Molecular Oncology

    Article Title: A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

    doi: 10.1002/1878-0261.70328

    Figure Lengend Snippet: Inhibiting eIF5A hypusination and unfolded protein response (UPR) activity. (A) Western blot of eIF5A hypusination in RPMI‐8226 and LP‐1 cells treated with GC7 (6 μ m ), N = 3, one representative experiment is shown. (B) Quantification of A. Data are presented as mean ± SEM. (C) Expression of key UPR proteins upon in RPMI‐8226 and LP‐1 cells treated with GC7 (6 μ m ), N = 2, one representative experiment is shown. (D) Viability of RPMI‐8226 cells treated with TG (6 n m ), GC7 (6 μ m ), and qVD (5 μ m ) for 24 h. Data are presented as mean ± SEM, N = 3. (E) Viability of LP‐1 cells treated with TG (6 n m ), GC7 (6 μ m ), and qVD (5 μ m ) for 48 h. Data are presented as mean ± SEM, N = 3. (F) Western blot of eIF5A hypusination in RPMI8226 mock cells after TG treatment (24 h, 6 n m ), N = 4, one representative experiment is shown. Data are presented as mean ± SEM. (G) Western blot of eIF5A hypusination in RPMI8226 cells treated with BO (24 h, 20 n m ), N = 3, one representative experiment is shown. Data are presented as mean ± SEM. (H) Western blot of eIF5A hypusination in LP‐1 mock cells after TG treatment (24 h, 12 n m ), N = 4, one representative experiment is shown. Data are presented as mean ± SEM. P ‐values were calculated using student's t ‐tests, * P < 0.05, ** P < 0.01. TG, thapsigargin.

    Article Snippet: RPMI‐8226 cells (RRID:CVCL_0014; obtained from ATCC), LP‐1 (RRID:CVCL_0012; obtained from DSMZ) and JeKo‐1 (RRID:CVCL_1865; obtained from DSMZ) were cultured in IMDM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin at 37 °C and 5% CO 2 .

    Techniques: Activity Assay, Western Blot, Expressing

    Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, LP‐1, and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.

    Journal: Molecular Oncology

    Article Title: A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

    doi: 10.1002/1878-0261.70328

    Figure Lengend Snippet: Relative fitness of mock vs EIF5A knockout (KO) cells in RPMI‐8226, LP‐1, and JeKo‐1 cells. (A) Competition assay in RPMI‐8226 wild‐type (WT) vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 ), qVD (5 μ m ) or TG (1 n m ), N = 3. Data are presented as mean ± SEM. (B) Competition assay in LP‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (1.5 n m ), N = 4. Data are presented as mean ± SD. (C) Competition assay in JeKo‐1 WT vs mock or vs EIF5A KO cells under basal conditions, with doxycycline (3 days, 1 μg·mL −1 n m ) or TG (2.5 n m ), N = 4. Data are presented as mean ± SD.

    Article Snippet: RPMI‐8226 cells (RRID:CVCL_0014; obtained from ATCC), LP‐1 (RRID:CVCL_0012; obtained from DSMZ) and JeKo‐1 (RRID:CVCL_1865; obtained from DSMZ) were cultured in IMDM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin at 37 °C and 5% CO 2 .

    Techniques: Knock-Out, Competitive Binding Assay